Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
15
×
clinical trials
15
×
life sciences
national blog main
biotech
national top stories
fda
san francisco blog main
new york blog main
boston
new york top stories
san francisco top stories
amgen
deals
san diego blog main
alnylam pharmaceuticals
cancer
roche
san diego top stories
alexion pharmaceuticals
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
europe blog main
inclisiran
indiana blog main
indiana top stories
investing
new york
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
regeneron pharmaceuticals
sanofi
seattle blog main
seattle top stories
texas blog main
What
drug
15
×
medicines
fda
ipo
cancer
new
therapeutics
brings
cholesterol
company
genetic
lead
market
medco
medicine
muscle
research
approval
bio
biotech
candidate
deal
disease
diseases
dyne
lowering
marketing
million
patients
pharma
pharmaceuticals
phase
pricing
raised
rare
ready
roche
targets
team
twice
Language
unset
15
×
Current search:
drug
×
unset
×
" clinical trials "
×
" boston top stories "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing